Skip to main content
Telesis Bio, Inc. (TBIO)
OTCMKTS · Delayed Price · Currency is USD
0.1210
+0.0005 (0.37%)
May 7, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Collaboration
8.69M
Log In
Log In
Log In
Log In
Collaboration Growth
30.68%
Log In
Log In
Log In
Log In
BioXP Systems
6.55M
Log In
Log In
Log In
Log In
BioXP Systems Growth
-1.57%
Log In
Log In
Log In
Log In
Services
6.23M
Log In
Log In
Log In
Log In
Services Growth
-23.08%
Log In
Log In
Log In
Log In
BioXP Kits
3.20M
Log In
Log In
Log In
Log In
BioXP Kits Growth
8.48%
Log In
Log In
Log In
Log In
Royalties and Other
2.84M
Log In
Log In
Log In
Log In
Royalties and Other Growth
3.13%
Log In
Log In
Log In
Log In
Benchtop Reagents
-
Log In
Log In
Log In
Log In
Benchtop Reagents Growth
-
Log In
Log In
Log In
Log In
Synthetic Biology Instruments, Reagents and Associated Products
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
North America
12.31M
Log In
Log In
Log In
Log In
North America Growth
56.62%
Log In
Log In
Log In
Log In
Europe/ Middle East/ Africa
2.24M
Log In
Log In
Log In
Log In
Europe/ Middle East/ Africa Growth
46.45%
Log In
Log In
Log In
Log In
Asia Pacific
1.44M
Log In
Log In
Log In
Log In
Asia Pacific Growth
-5.85%
Log In
Log In
Log In
Log In
United States
-
Log In
Log In
Log In
Log In